Literature DB >> 9438437

Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.

P J Pouwels1, J Frahm.   

Abstract

The regional distribution of brain metabolites was studied in several cortical white and gray matter areas, cerebellum, and thalamus of young adults with use of quantitative single-voxel proton MRS at 2.0 T. Whereas the neuronal compound N-acetylaspartate is distributed homogeneously throughout the brain, N-acetylaspartylglutamate increases caudally and exhibits higher concentrations in white matter than in gray matter. Creatine, myo-inositol, glutamate, and glutamine are less concentrated in cortical white matter than in gray matter. The highest creatine levels are found in cerebellum, parallel to the distribution of creatine kinase and energy-requiring processes in the brain. Also myo-inositol has highest concentrations in the cerebellum. Choline-containing compounds exhibit a marked regional variability with again highest concentrations in cerebellum and lowest levels and a strong caudally decreasing gradient in gray matter. The present findings neither support a metabolic gender difference (except for a 1.3-fold higher myo-inositol level in parietal white matter of female subjects) nor a metabolic hemispheric asymmetry.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9438437     DOI: 10.1002/mrm.1910390110

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  113 in total

1.  Volume-selective 1H MR spectroscopy for in vivo detection of valproate in patients with epilepsy.

Authors:  S Seyfert; J Bernarding; J Braun
Journal:  Neuroradiology       Date:  2003-03-27       Impact factor: 2.804

Review 2.  [(1)H magnetic resonance spectroscopy (MRS) of the liver and hepatic malignant tumors at 3.0 Tesla].

Authors:  F Fischbach; M Thormann; J Ricke
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

3.  Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: initial results.

Authors:  X Yao; M Zeng; H Wang; S Fei; S Rao; Y Ji
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

4.  In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice.

Authors:  Gülin Oz; Manda L Vollmers; Christopher D Nelson; Ryan Shanley; Lynn E Eberly; Harry T Orr; H Brent Clark
Journal:  Exp Neurol       Date:  2011-09-22       Impact factor: 5.330

5.  Striatal GABA-MRS predicts response inhibition performance and its cortical electrophysiological correlates.

Authors:  Clara Quetscher; Ali Yildiz; Shalmali Dharmadhikari; Benjamin Glaubitz; Tobias Schmidt-Wilcke; Ulrike Dydak; Christian Beste
Journal:  Brain Struct Funct       Date:  2014-08-26       Impact factor: 3.270

6.  The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

Authors:  Maartje M L De Win; Gerry Jager; Hylke K E Vervaeke; Thelma Schilt; Liesbeth Reneman; Jan Booij; Frank C Verhulst; Gerard J Den Heeten; Nick F Ramsey; Dirk J Korf; Wim Van den Brink
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

7.  Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla.

Authors:  Eva H Baker; Gianpaolo Basso; Peter B Barker; Mari A Smith; David Bonekamp; Alena Horská
Journal:  J Magn Reson Imaging       Date:  2008-03       Impact factor: 4.813

8.  Soft constraints in nonlinear spectral fitting with regularized lineshape deconvolution.

Authors:  Yan Zhang; Jun Shen
Journal:  Magn Reson Med       Date:  2012-05-22       Impact factor: 4.668

Review 9.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

10.  Newfound effect of N-acetylaspartate in preventing and reversing aggregation of amyloid-beta in vitro.

Authors:  Jean-Pierre Dollé; Jeffrey M Rodgers; Kevin D Browne; Thomas Troxler; Feng Gai; Douglas H Smith
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.